ConfX Global

Tempus AI

AI-enabled precision medicine combining genomic testing with clinical data.

Healthcare and life sciences technology

About

Tempus AI is a precision medicine company founded in Chicago in 2015 by Eric Lefkofsky, who is chief executive. It combines genomic sequencing and other diagnostic tests with a large library of clinical and molecular data, and uses AI to support treatment decisions for physicians and drug discovery and development for life sciences companies. Tempus is listed on Nasdaq and reported 2025 revenue of $1.27 billion. At the end of 2025 it had data agreements with more than 70 pharmaceutical customers worth over $1.1 billion in total contract value.

Key facts

Headquarters
Chicago, United States
Founded
2015
Chief executive
Eric Lefkofsky
Founders
Eric Lefkofsky
Regions served
United States
Markets
Healthcare and life sciences technology
Website
tempus.com

Products and solutions

  • Genomic and diagnostic testing
  • Clinical and molecular data for research